Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The value of the multiple sclerosis specialist nurse with respect to prevention of unnecessary emergency admission.
Withdrawal of fingolimod treatment for relapsing-remitting multiple sclerosis: report of six cases.
Biomarkers in multiple sclerosis.
Catheter venography and endovascular treatment of chronic cerebrospinal venous insufficiency.
Combined EPR and Molecular Modeling Study of PPI Dendrimers Interacting with Copper Ions: Effect of Generation and Maltose Decoration.
Ligation of the jugular veins does not result in brain inflammation or demyelination in mice.
Cost-effectiveness of early initiation of fingolimod versus delayed initiation after 1 year of intramuscular interferon Beta-1a in patients with multiple sclerosis.
Effect of Multiple Infusions of AIN457 on Disease Activity in Relapsing-remitting Multiple Sclerosis
miR-15a and 16-1 are downregulated in CD4(+) T cells of multiple sclerosis relapsing patients.
2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--I. Anticonvulsant properties.
A Population Approach to Characterize Interferon Beta-1b Effect on Contrast Enhancing Lesions in Patients With Relapsing Remitting Multiple Sclerosis.
Behavioral interventions in multiple sclerosis: a biopsychosocial perspective.
Genetic burden of common variants in progressive and bout-onset multiple sclerosis.
Multiple sclerosis relapses and depression.
PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews.
Resolution of autoimmune thrombocytopenia associated with raltegravir use in an HIV-positive patient.
Autoreactive CD19+CD20- Plasma Cells Contribute to Disease Severity of Experimental Autoimmune Encephalomyelitis.
Inhibition of SLPI ameliorates disease activity in experimental autoimmune encephalomyelitis.
Intramuscular interferon beta-1a is effective in Japanese patients with relapsing-remitting multiple sclerosis: a pre-treatment versus treatment comparison study of gadolinium-enhanced MRI brain lesions.
Cortical lesion load correlates with diffuse injury of multiple sclerosis normal appearing white matter.
Severe auto-immune hemolytic anemia in a fingolimod-treated multiple sclerosis patient.
Reward responsiveness and fatigue in multiple sclerosis.
Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice.
Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss.
Multiple cutaneous necrotic lesions associated with Interferon beta-1b injection for multiple sclerosis treatment: A case report and literature review.

Pages